
Opinion|Videos|April 8, 2024
Acknowledging Opportunities for Further Research in AD Management
Author(s)David Rosmarin, MD
David Rosmarin, MD, acknowledges opportunities for further research in diverse populations to continue updating AD treatment guidelines.
Advertisement
Episodes in this series

In the Dermatology Times Expert Perspectives series "Advancements in Atopic Dermatitis: Insights from the 2024 Masterclasses in Dermatology Conference," leading dermatologists discuss the advancements in treatments and data for atopic dermatitis (AD) with hand-foot involvement, diversity in clinical trials, and pearls from the American Academy of Dermatology's (AAD) AD treatment guidelines.
In this episode, David Rosmarin, MD, of Indiana University in Indianapolis, acknowledges opportunities for further research in diverse populations to continue updating AD treatment guidelines.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
The Evolving CSU Pipeline: Biologics, BTK Inhibitors, and Biomarker-Guided Care
2
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
3
Taltz Plus Zepbound Show Durable Year 1 Efficacy in Psoriatic Disease
4
10 Skin Cancer Exam Tips
5












